Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
This study is currently recruiting participants.
Study NCT00048880   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 8, 2002   Last Updated: June 19, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms
Interventions listed in this trial
HeFi-1 Monoclonal Antibody
Additional drug interventions recognized in this trial
Antibodies
Antibodies, Monoclonal
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services